Topics: pharmaceuticals

Interview: Biojobz CEO Dr. Ganesh Nikam on a Tailored Approach to Biopharma Hiring

In an interview with TechGraph, Dr. Ganesh Nikam Managing Director & CEO of Biojobz shares his insight into the company's unique approach to addressing...

Almirall onboards Mercedes Diz as VP of Corporate Strategy

Spanish biopharmaceutical company, Almirall has announced the appointment of Mercedes Diz as Vice President (VP) of Corporate Strategy. Diz joined Almirall in 2002 and, since...

PAG led API Platform to Acquire Controlling stake in Optimus Drugs

PAG, a leading alternative investment firm focused on Asia-Pacific, announced today that its private equity strategy, along with consortium partners CX Partners and Samara...
- Advertisement -

Unicommerce: Ecommerce records 31% growth in Q3 2020

Unicommerce, India's largest e-commerce focused SaaS platform, released e-commerce trends for the third quarter of the year 2020. Post the lockdown has been lifted...

WhizAI secures $4 million to bring cognitive insights to life sciences

Somerset, New Jersey-based AI platform for enterprises WhizAI has raised $4 million in series seed round funding from Healthy Ventures. A new round of funding,...

Liberty General Insurance launches ‘Critical Connect’ health insurance policy

Mumbai-based insurance company, Liberty General Insurance has announced the launch of 'Critical Connect' - a health insurance policy that covers up to 60 critical...
- Advertisement -

Carlyle Group picks 20 percent share in Piramal Pharma for $490 million

Piramal Enterprises Limited on Saturday said, "Global investment firm Carlyle Group has agreed to invest around $490 million to pick 20 percent stake in...

Glenmark Pharma records 36.28% increase in Q4 profit at Rs 220 crore

Mumbai-based drugmaker Glenmark Pharma on Friday said, "It has reported a 36.28 percent increase in its consolidated net profit to Rs 220.3 crore in...

Metropolis Healthcare promoter divested 6.03 percent shares for Rs 422.58 crore

Mumbai-based diagnostic company Metropolis Healthcare has said, "Its promoter has divested 6.03 percent shares in the company for Rs 422.58 crore." In a filing with...
- Advertisement -

Jubilant Life Sciences partners with Gilead Sciences to develop remdesivir

India-based drugmaker Jubilant Life Sciences on Tuesday said that "It's subsidiary Jubilant Generics Limited has entered into a non-exclusive agreement with Gilead Sciences to...

Trending